Astelin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

DYmista NAsal Spray in CHInese Patients
Condition:   Allergic Rhinitis Interventions:   Drug: Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT;   Drug: Azelastine Hydrochloride 0.137 MG/ACTUAT;   Drug: Fluticasone Propionate 0.05 MG/ACTUAT Sponsor:   MEDA Pharma GmbH & Co. KG Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2018 Category: Research Source Type: clinical trials

MP-AzeFlu Allergen Chamber - Onset of Action Study
Condition:   Seasonal Allergic Rhinitis Interventions:   Drug: Azelastine hydrochloride + fluticasone propionate nasal spray;   Drug: Placebos;   Drug: fluticasone propionate nasal spray + loratadine Sponsor:   MEDA Pharma GmbH & Co. KG Not yet recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2016 Category: Research Source Type: clinical trials